Akaza Research Releases OpenClinica 3.0 Electronic Data Capture Software
Waltham, MA
Akaza Research announced the release of OpenClinica 3.0, the newest version of the open source electronic data capture (EDC) software for clinical trials. This latest production release adds a host of new capabilities designed to further accelerate the adoption of open source into mainstream research.
“We have added powerful new capabilities and made them accessible through an intelligent, task-oriented user interface," said Cal Collins, CEO of Akaza Research.
Key features of OpenClinica 3.0 include: streamlined user interface that simplifies site usage, study progress dashboard, improved query workflows, with notifications, chain of custody, and task management, source data verification workspace, faster page load time, dedicated Study Build module, improved control over significant digits in eCRF data items, job scheduler and web services interface to allow for programmatic data interchange with other systems
As open source software, OpenClinica is free for organizations to use and modify. The software may be downloaded here. Akaza Research will be conducting a webinar presentation of OpenClinica 3.0 on October 28, 2009 to demonstrate the new product and answer questions form the community, click here for information.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
